The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Nussbaum Ran since year 2005.
The trader's CIK number is 1609805.
At the time of this reporting, Nussbaum Ran is the Director of Arqule Inc .
(stock ticker symbol ARQL).
See this page for all insider trading activities at Arqule Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-04-30||ELOX||Eloxx Pharmaceuticals, Inc.||Buy||350,000||9.75||3,412,500|
|2018-03-22||ELOX||Eloxx Pharmaceuticals, Inc.||Buy||6,000||8.00||48,000|
|2018-03-21||ELOX||Eloxx Pharmaceuticals, Inc.||Buy||6,600||7.55||49,830|
|2017-05-09||KITE||Kite Pharma, Inc.||Buy||9,832||69.11||679,519|
|2015-06-01||KITE||Kite Pharma, Inc.||Sale||80,760||56.29||4,545,980|
|2015-06-02||KITE||Kite Pharma, Inc.||Sale||224,674||55.67||12,508,724|
|2015-03-27||KITE||Kite Pharma, Inc.||Sale||77,873||61.24||4,769,020|
|2015-03-30||KITE||Kite Pharma, Inc.||Sale||115,857||59.91||6,941,456|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nussbaum Ran (Director of Arqule Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.